VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CRBU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CRBUCaribou Biosciences, Inc.
$0.33$32M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRBUQuarterly Financials

Caribou Biosciences, Inc. (CRBU) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Caribou Biosciences, Inc. (CRBU) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CRBU Income Statement

Quarterly statement

CRBU Income Statement

Caribou Biosciences, Inc. (CRBU) annual income statement — 7-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue1.61M1.5M2.4M3.94M2.2M2.67M2.35M2.08M2.02M3.46M2.43M3.56M23.66M3.75M3.5M3.69M3.3M4.19M2.66M2.56M
Revenue Growth %-26.89%-43.79%1.87%89.74%8.6%-23.01%-3.13%-41.62%-91.45%-7.75%-30.64%-3.63%616.38%-10.42%31.46%44.28%-16.95%184.01%67.97%160.06%
Cost of Goods Sold00649K022.4M1.3M1.74M29.86M29.82M856K710K1.97M28.58M26.5M25.71M25.74M022.58M13.92M273K
COGS % of Revenue--27.08%-1019.15%48.67%74.08%1437.84%1473.37%24.71%29.23%55.48%120.8%705.81%734.12%697.07%-538.62%522.67%10.67%
Gross Profit1.61M1.5M1.75M3.94M-20.2M1.37M610K-27.79M-27.8M2.61M1.72M1.58M-4.92M-22.75M-22.21M-22.04M3.3M-18.39M-11.26M2.29M
Gross Margin %100%100%72.92%100%-919.15%51.33%25.92%-1337.84%-1373.37%75.29%70.77%44.52%-20.8%-605.81%-634.12%-597.07%100%-438.62%-422.67%89.33%
Gross Profit Growth %107.95%9.5%186.56%114.18%27.32%-47.51%-64.51%-1854.23%-464.75%111.46%107.74%107.19%-249.02%-23.72%-97.22%-1064.3%127.86%-1345.73%-31.25%120.71%
Operating Expenses29.25M26.84M28.03M32.39M9.2M48.95M43.52M11.09M10.44M46.11M47.72M39.03M9.71M10.12M8.91M8.53M29.84M10.04M9.59M22.69M
OpEx % of Revenue1820.1%1790.39%1169.3%821.97%418.43%1835.28%1849.68%533.85%515.86%1331.09%1964.64%1096.85%41.04%269.51%254.4%231.15%903.42%239.6%360.1%886.71%
Selling, General & Admin7.9M7.9M8.07M8.58M9.2M10.4M9.73M10.49M5.94M10.63M14.64M7.75M9.71M10.12M8.91M8.53M9.85M10.04M9.59M7.58M
SG&A % of Revenue491.6%526.75%336.5%217.69%418.43%390.06%413.73%504.96%293.53%306.84%602.84%217.73%41.04%269.51%254.4%231.15%298.18%239.6%360.1%296.21%
Research & Development21.35M18.94M20.61M23.82M22.4M27.69M35.53M30.46M30.42M35.48M33.79M31.28M28.58M26.5M25.71M26.34M19.99M22.58M13.92M15.11M
R&D % of Revenue1328.5%1263.64%859.87%604.29%1019.15%1038.32%1510.03%1466.73%1503.01%1024.25%1391.03%879.12%120.8%705.81%734.12%713.33%605.24%538.62%522.67%590.5%
Other Operating Expenses00-649K0-1000K1000K-1000K-1000K-1000K0-710K0-1000K-1000K-1000K-1000K0-1000K-1000K0
Operating Income-27.64M-25.34M-26.28M-28.45M-29.4M-47.58M-42.91M-38.88M-38.24M-43.5M-46M-37.44M-14.63M-32.87M-31.12M-30.58M-26.54M-28.43M-20.85M-20.41M
Operating Margin %-1720.1%-1690.39%-1096.37%-721.97%-1337.58%-1783.95%-1823.76%-1871.69%-1889.23%-1255.8%-1893.87%-1052.33%-61.84%-875.31%-888.52%-828.22%-803.42%-678.22%-782.77%-797.38%
Operating Income Growth %5.98%46.74%38.76%26.81%23.11%-9.37%6.71%-3.83%-161.31%-32.35%-47.84%-22.45%44.86%-15.61%-49.22%-49.86%-42.55%-78.09%-58.28%-34.13%
EBITDA-26.72M-24.71M-25.63M-27.77M-28.77M-46.41M-41.75M-37.69M-37.06M-42.65M-45.29M-36.7M-13.05M-32.25M-30.53M-30.07M-26.09M-28.07M-20.55M-20.13M
EBITDA Margin %-1662.91%-1648.7%-1069.3%-704.67%-1308.87%-1740.19%-1774.25%-1814.68%-1831.08%-1231.09%-1864.64%-1031.53%-55.17%-858.88%-871.7%-814.52%-789.8%-669.68%-771.21%-786.71%
EBITDA Growth %7.11%46.75%38.61%26.32%22.37%-8.83%7.82%-2.69%-183.91%-32.23%-48.37%-22.05%49.96%-14.88%-48.59%-49.37%-42.12%-78.42%-58.6%-34.28%
D&A (Non-Cash Add-back)919K625K649K682K631K1.17M1.17M1.18M1.18M856K710K740K1.58M617K589K506K450K358K308K273K
EBIT-26.61M-26.4M-25.09M-27.04M-27.55M-35.43M-39.99M-38.27M-34.68M-37.7M-41.23M-34.31M-14.63M-32.87M-31.12M-30.58M-26.54M-28.43M-20.85M-18.16M
Net Interest Income0000000000004.77M00000251K76K
Interest Income0000000000004.77M00000251K76K
Interest Expense00000000000000000000
Other Income/Expense1.03M1.06M1.2M1.42M1.85M-6.52M2.92M3.38M3.55M5.8M4.77M3.13M4.63M3.35M3.07M3.66M-110K1.73M1.76M2.25M
Pretax Income-26.61M-24.28M-25.09M-27.04M-27.55M-54.1M-39.99M-35.5M-34.68M-37.7M-41.23M-34.31M-10M-29.52M-28.04M-26.92M-26.65M-26.7M-19.09M-18.16M
Pretax Margin %-1656.01%-1619.88%-1046.52%-686.07%-1253.32%-2028.42%-1699.58%-1709.15%-1713.64%-1088.25%-1697.57%-964.36%-42.27%-786.13%-800.8%-729.12%-806.75%-636.86%-716.52%-709.57%
Income Tax000-550K000-9K000193K00070K000321K
Effective Tax Rate %0%0%0%2.03%0%0%0%0.03%0%0%0%-0.56%0%0%0%-0.26%0%0%0%-1.77%
Net Income-26.61M-24.28M-25.09M-26.49M-27.55M-54.1M-39.99M-35.49M-34.68M-37.7M-41.23M-34.51M-10M-29.52M-28.04M-26.99M-26.65M-26.7M-19.09M-18.48M
Net Margin %-1656.01%-1619.88%-1046.52%-672.11%-1253.32%-2028.42%-1699.58%-1708.71%-1713.64%-1088.25%-1697.57%-969.79%-42.27%-786.13%-800.8%-731.01%-806.75%-636.86%-716.52%-722.12%
Net Income Growth %3.4%55.11%37.27%25.36%20.57%-43.51%3.01%-2.85%-246.77%-27.7%-47.03%-27.85%62.46%-10.57%-46.92%-46.05%-27.05%-86.55%-45.06%-25.68%
Net Income (Continuing)-26.61M-24.28M-25.09M-26.49M-27.55M-54.1M-39.99M-35.49M-34.68M-37.7M-41.23M-34.51M-10M-29.52M-28.04M-26.99M-26.65M-26.7M-19.09M-18.48M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.25-0.24-0.26-0.28-0.30-0.58-0.43-0.39-0.38-0.42-0.46-0.39-0.12-0.48-0.46-0.44-0.44-0.44-0.32-0.31
EPS Growth %16.67%58.62%39.53%28.21%21.05%-38.1%6.52%0%-216.67%12.5%0%11.36%72.73%-9.09%-43.75%-41.94%4.35%-69.23%33.33%41.51%
EPS (Basic)-0.25-0.24-0.26-0.28-0.30-0.58-0.43-0.39-0.38-0.42-0.46-0.39-0.12-0.48-0.46-0.44-0.44-0.44-0.32-0.31
Diluted Shares Outstanding107.54M100.99M95.86M94.54M93.29M93.03M92.68M90.32M90.46M90.34M89.3M88.43M83.78M61.42M61.19M61M60.89M60.76M60.55M60.18M
Basic Shares Outstanding107.54M100.99M95.86M94.54M93.29M93.03M92.68M90.32M90.46M90.34M89.3M88.43M83.78M61.42M61.19M61M60.89M60.76M60.55M60.18M
Dividend Payout Ratio--------------------